|
John is admitted to practice
before the California Supreme Court and the United
States District Court for the Northern District of California. He is
a Registered Patent Attorney, admitted to practice before the United
States Patent and Trademark Office.
John represents clients
before the U.S. Patent and Trademark Office and in worldwide patent prosecution
strategies. His practice focuses on various aspects of patent law, including
patent prosecution and client counseling.
Prior to entering the legal profession, John worked as an assistant
research professor (at Rutgers University) and a research scientist (at
AMUR Pharmaceuticals). As a scientist, he made significant contributions in
cancer research and pharmacology. John has published over 20 peer-reviewed
articles in journals such as Biochemistry, FASEB Journal, Cancer Research,
Molecular Pharmacology, Chemical Research in Toxicology, and Biochemical
Journal.
John holds a B.S. in
Chemistry and a Ph.D. in Biochemistry, both from the University
of California at Los Angeles (UCLA), and a J.D. from
Northwestern California University School of Law. After receiving his J.D.,
John was an associate with Enterprise Law Group, Dehlinger & Associates,
and Dorsey & Whitney where he concentrated on patent prosecution, freedom-to-operate
analysis, and litigation support. He has also served as in-house patent
attorney at Transgenomic Inc., and at Agilent Technologies, where he managed
patent portfolios related to genomics analysis, provided licensing support, and
participated in due diligence related to SEC filings. John’s practice includes
patent preparation, prosecution, competitive patent analysis, preparation
of validity, infringement and patentability opinions, and strategic patent
portfolio management, specializing in the chemical, pharmaceutical and
biotechnological fields.
John is familiar with
technologies in diverse areas such as immunology, biochemistry and biophysics
of membranes and membrane proteins, nucleic acid structures and drug binding,
molecular biology and gene therapy, transgenic plants and animals, physiology
and pharmacology, new chemical entities, pharmaceutical formulations and
methods of treatment, natural products, analytical and diagnostic
instrumentation, nucleic acid micro-arrays, nucleic acid chromatography,
molecular toxicology, immunodiagnostics, bio-nanotechnology, and medical
devices.
|
